(Biokin) reported positive results from a prespecified interim analysis of the randomized Phase 3 PANKU-Breast01 study ...

PANKU-Breast01: Iza-bren cut progression or death risk by 59% vs chemotherapy in pretreated HR+/HER2− advanced breast cancer.

BioNTech enters a clinical trial collaboration with Gilead Sciences with the aim of improving outcomes in patients with PD-L1 low or negative triple-negative breast cancerThe global Phase 3 ROSETTA Br ...

BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced a clinical trial collaboration and supply agreement with Gilead ...

BioNTech SE announced a clinical trial collaboration and supply agreement with Gilead Sciences Inc. (?Gilead?) to evaluate pumitamig in combination with the TROP2-directed antibody-drug conjugate ...

Seven weeks after six opposition parties prepared five documents to guide cooperation ahead of the 2027 elections, consultations with presidential candidates have advanced, but the documents' status ...

Rakovina has advanced the program from target specification through lead generation and five cycles of iterative lead optimization in approximately two years, using Variational AI’s Enki™ generative ...

Ivonescimab was invented by Akeso Inc. (HKEX Code: 9926.HK) and is currently utilized in multiple Phase III clinical trials. Over 5,000 patients have been treated with ivonescimab in clinical studies ...

A near-infrared fluorescent choline kinase α inhibitor, JAS239, was used to identify tumors in canine patients.

The Zamfara State Police Command has held a peace accord signing and election security summit for chairmen and candidates of ...

OTTAWA - Prime Minister Mark Carney says it was "a great result for Canada" when Albertans chose unity in a referendum on ...